Advertisement

Topics

Zymergen Company Profile

07:33 EST 19th January 2019 | BioPortfolio

Zymergen is a molecular technology company ushering in a new age of manufacturing and industrial innovation. Leveraging the power of machine learning, automation, and bioengineering, Zymergen takes a radically different approach to improving the performance of materials and to discovering new molecular products that touch every industry -- from agriculture to chemicals and materials, pharmaceuticals, and more. The technology is in use today, serving Fortune 500 companies and major corporations across the globe.


News Articles [7 Associated News Articles listed on BioPortfolio]

Zymergen raises $400M+ to deliver AI-enabled biology to global bio-based industry

Zymergen announced a $400+ million Series C funding round in support of its proprietary technology platform to produce novel and improved molecules to meet global-scale industrial needs. The majority ...

Zymergen, molecular manufacturing tech co. Announces $400M in Series C Funding led by the SoftBank Vision Fund https://www.businesswire.com/news/home/20181213005198/en/Zymergen-Announces-400-Million-Series-Funding-led …

Zymergen, molecular manufacturing tech co. Announces $400M in Series C Funding led by the SoftBank Vision Fund https://www.businesswire.com/news/home/20181213005198/en/Zymergen-Announces-400-Million-...

Zymergen Appoints Jens Peter Clausen as Senior Vice President, Global Manufacturing

Molecular technology company expands manufacturing leadership with appointment of former Tesla Vice President and LEGO Group executive Zymergen, the world's first molecular ma...

Digest #253 – $1.2 billion in 1 week: Moderna $604M IPO, Zymergen $400M, Synthorx $131M IPO, Synthace $25.6M, Elemental Machines $9M, GenEdit $8.5M + our early bird ends Friday!

  Your guide to what’s new in synthetic biology Hi all, It’s been a phenomenal week for the synthetic biology industry with $1.2B flowing into the industry from a couple of big IPOs and s...

Zymergen raises more than $400M in series C

Management tracks: United Neuroscience, Zymergen

Zymergen Announces $400 Million in Series C Funding led by the SoftBank Vision Fund

Institutional investors rally behind molecular technology’s blue-chip market opportunity Zymergen, the world’s first molecular manufacturing technology company, ann...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Zymergen

Zymergen is a molecular technology company ushering in a new age of manufacturing and industrial innovation. Leveraging the power of machine learning, automation, and bioengineeri...

More Information about "Zymergen" on BioPortfolio

We have published hundreds of Zymergen news stories on BioPortfolio along with dozens of Zymergen Clinical Trials and PubMed Articles about Zymergen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zymergen Companies in our database. You can also find out about relevant Zymergen Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record